换一批Efficacy and safety of ezetimibe/simvastatin association on non-diabetic and diabetic patients with polygenic hypercholesterolemia or combined hyperlipidemia and previously intolerant to standard statin treatment.
第一作者：
Giuseppe,Derosa
第一单位：
Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy. giuseppe.derosa@unipv.it
作者：
医学主题词
抗胆固醇血症药(Anticholesteremic Agents);吖丁啶类(Azetidines);胆固醇, HDL(Cholesterol, HDL);胆固醇, LDL(Cholesterol, LDL);糖尿病, 2型(Diabetes Mellitus, Type 2);复方合剂(Drug Combinations);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);高脂血症, 家族性混合性(Hyperlipidemia, Familial Combined);男(雄)性(Male);中年人(Middle Aged);患病率(Prevalence);斯伐他汀(Simvastatin);甘油三酯类(Triglycerides)
DOI
10.1111/j.1365-2710.2008.01004.x
PMID
19650249
发布时间
2019-10-27
- 浏览23
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
